Navigation Links
Vici Health Sciences Expands Staff and Footprint in Maryland to Meet Customer Demands
Date:12/31/2019

Vici Health Sciences announces it is breaking ground in expanding its pharmaceutical product development lab in Maryland. Emphasis will be in expanding capabilities in both oral and parenteral dosage forms. With the increased size and expanded capabilities, Vici Health Sciences will be well positioned to meet the growing demand for its pharmaceutical formulation and analytical method development services. Founded in 2016 with the aim of rapidly developing drugs to meet acute and long-term market needs, Vici currently works with over 10 different pharmaceutical companies and continues to expand its client base. The current expansion is focused on improving capabilities in manufacturing GMP clinical supplies and increases Vici’s ability to handle additional clients simultaneously.

Dr Anish Dhanarajan, CEO and co-founder stated: “We work hard to provide our clients innovative R&D solutions to bring their drugs to the market. Our clients want to develop high quality pharmaceutical drug products rapidly and clearly recognize the value we are able to provide. This expansion will allow us to meet the growing demand for our services.”

About Vici Health Sciences LLC
Vici Health Sciences (Vici) is a U.S. based pharmaceutical research and development company. Vici is focused on providing innovative, flexible, high quality, and low-cost R&D services to small and mid-sized pharmaceutical companies that need to grow their product portfolio. Vici currently focuses on oral and injectable dosage forms and operates an R&D and GMP facility capable of developing formulations, analytical methods, and manufacturing phase 1/pilot clinical supplies.

Read the full story at https://www.prweb.com/releases/vici_health_sciences_expands_staff_and_footprint_in_maryland_to_meet_customer_demands/prweb16809028.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
2. Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark
3. Leading Experiential Marketing Agency, Sparks, Invests in Healthcare Marketing Firm, Bichsel Medical Marketing Group
4. Tech PR Firm ARPR Honored as a Health Care PR Agency of the Year; Grows HealthIT Practice Group 18% Quarter-Over-Quarter
5. BHIP Takes Aim at Teenagers’ Stress, Anxiety, Executive Function, Interpersonal Skills, and Overall Mental Health
6. eKare’s inSight Joins the NHS Digital Health Accelerator Program
7. Advancements Announces New Episode Focusing on Innovations in Health, Medicine, and Technology
8. MyBioGate Global Healthcare Innovation Competition Boston Preliminary Successfully Came to the Conclusion
9. Visikol Presents on Imaging 3D Cell Culture Models at the National Institute of Health
10. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
11. Centura Health’s Innovative Patient Experience Initiative for Needle-Free Blood Draws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2020)... ... February 11, 2020 , ... ... from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation ... Unlike extension block design, the Inspan device fixates the spine to allow ...
(Date:2/5/2020)... BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise ... patients’ lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare ...
(Date:1/28/2020)... (PRWEB) , ... January 28, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced the release of ... reinforces Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) for ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive surgeons ... in New Jersey epitomize the notion that plastic surgery is much more than just ... popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew Elkwood, ...
Breaking Biology Technology:
(Date:2/13/2020)... ... February 13, 2020 , ... Pharmica Consulting ... clinical operations executives and focusing on all facets of clinical trial planning and ... patient engagement, and more. , “We have attended the SCOPE Summit every ...
(Date:2/11/2020)... HOUSTON (PRWEB) , ... February 11, 2020 , ... ... engineering firm, is pleased to announce it achieved its ISO 9001:2015 registration by ... In preparation for the audits, she reviewed and revised all existing Standard Operating ...
(Date:2/11/2020)... ... February 11, 2020 , ... The LaunchPort™ announced today ... in Port Covington, Baltimore. The newly formed company is developing a novel pulsatile ... increased demand for home dialysis treatments. The start-up company will be moving research ...
Breaking Biology News(10 mins):